UPDATE 1-Mersana's cancer drug trial put on hold by FDA; shares halted
July 19, 2018 at 08:36 AM EDT
Mersana Therapeutics said on Thursday an early stage trial testing its lead cancer drug has been put on partial hold by the U.S. Food and Drug Administration after a patient's death was possibly linked to the treatment.